High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 10/15/2027
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The in...
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 01/07/2028
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant ...
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 05/21/2025
DUE: 01/11/2026
This Notice of Funding Opportunity (NOFO) supports applications to develop and implement a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, ...
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
$650,000
HHS-NIH11
POSTED: 12/11/2024
UPDATED: 12/11/2024
DUE: 10/19/2027
The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implem...
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
$4,000,000
HHS-NIH11
POSTED: 12/10/2025
UPDATED: 12/10/2025
DUE: 05/26/2028
Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute ...
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/10/2024
UPDATED: 12/10/2024
DUE: 01/07/2028
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant ...
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
HHS-NIH11
POSTED: 12/10/2024
UPDATED: 06/05/2025
DUE: 06/18/2026
The National Center for Advancing Translational Sciences (NCATS) invites applications for the Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) Notice of Funding Opportun...
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 12/09/2024
UPDATED: 12/10/2024
DUE: 05/28/2027
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that comp...
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
HHS-NIH11
POSTED: 12/10/2024
UPDATED: 03/26/2025
DUE: 09/28/2026
The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a ti...
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
HHS-NIH11
POSTED: 12/10/2024
UPDATED: 12/10/2024
DUE: 09/28/2027
The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The p...